查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1378888

2023-2028 年按疫苗類型、產品類型、配銷通路（分銷合作夥伴公司、非政府組織、政府機構）、最終用戶和地區分類的肺炎球菌疫苗市場報告

Pneumococcal Vaccine Market Report by Vaccine Type, Product Type, Distribution Channel (Distribution Partner Companies, Non-Governmental Organizations, Government Authorities), End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球肺炎鏈球菌疫苗市場規模達到89億美元。展望未來， IMARC Group預計到2028年市場規模將達到122億美元，2022-2028年複合年成長率（CAGR）為5.4%。

肺炎鏈球菌疾病是由肺炎鏈球菌引起的，可導致肺部（肺炎）和血液（菌血症）或大腦和脊髓內膜（腦膜炎）的嚴重感染。這些疫苗透過刺激免疫系統並防止導致嚴重感染的細菌菌株來幫助保護兒童和成人。由於這些疫苗有助於防止感染傳播、降低死亡率並消除住院治療的需要，因此在全球範圍內廣泛使用。

根據世界衛生組織 (WHO) 的數據，2-5 歲以下的兒童患肺炎球菌疾病的風險很高。再加上出生率的不斷上升以及父母對孩子健康的日益擔憂，這是推動市場成長的主要因素之一。此外，老年人口的增加也促進了市場的成長。這也可以歸因於該疾病的傳染性，這可能會導致老年人出現嚴重的併發症。此外，吸菸者和慢性病患者數量的增加正在對市場成長產生積極影響。此外，許多國家的管理機構在嬰兒常規免疫中引入肺炎球菌結合疫苗（PCV）預計將推動市場成長。

本報告回答的關鍵問題

  • 2022年全球肺炎鏈球菌疫苗市場規模有多大？
  • 2023-2028年全球肺炎鏈球菌疫苗市場的預期成長率是多少？
  • COVID-19 對全球肺炎鏈球菌疫苗市場有何影響？
  • 推動全球肺炎鏈球菌疫苗市場的關鍵因素是什麼？
  • 根據疫苗類型，全球肺炎鏈球菌疫苗市場的分佈如何？
  • 根據產品類型，全球肺炎鏈球菌疫苗市場的細分如何？
  • 根據配銷通路，全球肺炎鏈球菌疫苗市場的細分如何？
  • 全球肺炎鏈球菌疫苗市場的重點區域有哪些？
  • 全球肺炎鏈球菌疫苗市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球肺炎鏈球菌疫苗市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按疫苗類型分類的市場區隔

  • 肺炎鏈球菌結合疫苗
    • 市場走向
    • 市場預測
  • 肺炎鏈球菌多醣體疫苗
    • 市場走向
    • 市場預測

第 7 章：按產品類型分類的市場區隔

  • 普雷夫納爾 13
    • 市場走向
    • 市場預測
  • 合成花
    • 市場走向
    • 市場預測
  • 肺炎疫苗23
    • 市場走向
    • 市場預測

第 8 章：按配銷通路分類的市場區隔

  • 分銷合作夥伴公司
    • 市場走向
    • 市場預測
  • 非政府組織 (NGO)
    • 市場走向
    • 市場預測
  • 政府機關
    • 市場走向
    • 市場預測

第 9 章：最終用戶的市場區隔

  • 兒科
    • 市場走向
    • 市場預測
  • 成年人
    • 市場走向
    • 市場預測

第 10 章：按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Astellas Pharma Inc.
    • GlaxoSmithKline Plc.
    • Merck & Co. Inc.
    • Panacea Biotec Ltd.
    • Pfizer Inc.
    • Sanofi SA
    • Serum Institute of India Pvt Ltd.
    • Walvax Biotechnology Co. Ltd.
Product Code: SR112023A3133

Abstract

The global pneumococcal vaccine market size reached US$ 8.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2022-2028.

Pneumococcal disease is caused by Streptococcus pneumoniae bacterium that can lead to severe infection of the lungs (pneumonia) and blood (bacteremia) or the lining of the brain and spinal cord (meningitis). The vaccines help protect both children and adults by stimulating the immune system and protecting against the bacterial strains responsible for severe infections. As these vaccines help prevent infection from spreading, reduce fatality rate and eliminate the need for hospitalization, they are widely being used across the globe.

According to the World Health Organization (WHO), children under 2-5 years of age are at a high risk of developing pneumococcal disease. This, in confluence with the escalating number of birth rates and the growing concerns among parents about the health of their children, represents one of the major factors bolstering the market growth. Additionally, the increasing geriatric population is contributing to the market growth. This can also be accredited to the contagiousness of the disease, which can cause severe complications in older adults. Furthermore, the rising number of smokers and individuals living with chronic health conditions is positively influencing the market growth. Moreover, the introduction of the Pneumococcal Conjugate Vaccine (PCV) in infant routine immunization by governing agencies of numerous countries is anticipated to propel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pneumococcal vaccine market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on vaccine type, product type, distribution channel and end user.

Breakup by Vaccine Type:

Pneumococcal Conjugate Vaccine

Pneumococcal Polysaccharide Vaccine

Breakup by Product Type:

Prevnar 13

Synflorix

Pneumovax 23

Breakup by Distribution Channel:

Distribution Partner Companies

Non-Governmental Organizations (NGO)

Government Authorities

Breakup by End User:

Pediatrics

Adults

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., GlaxoSmithKline Plc., Merck & Co. Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt Ltd and Walvax Biotechnology Co. Ltd.

Key Questions Answered in This Report

  • 1. What was the size of the global pneumococcal vaccine market in 2022?
  • 2. What is the expected growth rate of the global pneumococcal vaccine market during 2023-2028?
  • 3. What has been the impact of COVID-19 on the global pneumococcal vaccine market?
  • 4. What are the key factors driving the global pneumococcal vaccine market?
  • 5. What is the breakup of the global pneumococcal vaccine market based on the vaccine type?
  • 6. What is the breakup of the global pneumococcal vaccine market based on the product type?
  • 7. What is the breakup of the global pneumococcal vaccine market based on the distribution channel?
  • 8. What are the key regions in the global pneumococcal vaccine market?
  • 9. Who are the key players/companies in the global pneumococcal vaccine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pneumococcal Vaccine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Vaccine Type

  • 6.1 Pneumococcal Conjugate Vaccine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Pneumococcal Polysaccharide Vaccine
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Prevnar 13
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Synflorix
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Pneumovax 23
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Distribution Partner Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Non-Governmental Organizations (NGO)
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Government Authorities
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pediatrics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Adults
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Astellas Pharma Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 GlaxoSmithKline Plc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Merck & Co. Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Panacea Biotec Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Pfizer Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Sanofi S.A.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Serum Institute of India Pvt Ltd.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Walvax Biotechnology Co. Ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials

List of Figures

  • Figure 1: Global: Pneumococcal Vaccine Market: Major Drivers and Challenges
  • Figure 2: Global: Pneumococcal Vaccine Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Pneumococcal Vaccine Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Pneumococcal Vaccine Market: Breakup by Vaccine Type (in %), 2022
  • Figure 5: Global: Pneumococcal Vaccine Market: Breakup by Product Type (in %), 2022
  • Figure 6: Global: Pneumococcal Vaccine Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Pneumococcal Vaccine Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Pneumococcal Vaccine Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Pneumococcal Vaccine (Pneumococcal Conjugate Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Pneumococcal Vaccine (Pneumococcal Conjugate Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Pneumococcal Vaccine (Pneumococcal Polysaccharide Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Pneumococcal Vaccine (Pneumococcal Polysaccharide Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Pneumococcal Vaccine (Prevnar 13) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Pneumococcal Vaccine (Prevnar 13) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Pneumococcal Vaccine (Synflorix) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Pneumococcal Vaccine (Synflorix) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Pneumococcal Vaccine (Pneumovax 23) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Pneumococcal Vaccine (Pneumovax 23) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Pneumococcal Vaccine (Distribution Partner Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Pneumococcal Vaccine (Distribution Partner Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Pneumococcal Vaccine (Non-Governmental Organizations-NGO) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Pneumococcal Vaccine (Non-Governmental Organizations-NGO) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Pneumococcal Vaccine (Government Authorities) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Pneumococcal Vaccine (Government Authorities) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Pneumococcal Vaccine (Pediatrics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Pneumococcal Vaccine (Pediatrics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Pneumococcal Vaccine (Adults) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Pneumococcal Vaccine (Adults) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: North America: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: North America: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: United States: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: United States: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Canada: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Canada: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Asia-Pacific: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Asia-Pacific: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: China: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: China: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Japan: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Japan: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: India: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: India: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: South Korea: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: South Korea: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Australia: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Australia: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Indonesia: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Indonesia: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Others: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Others: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Europe: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Europe: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Germany: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Germany: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: France: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: France: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: United Kingdom: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: United Kingdom: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Italy: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Italy: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Spain: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Spain: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Russia: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Russia: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Others: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Others: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Latin America: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Latin America: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Brazil: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Brazil: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Mexico: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Mexico: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Middle East and Africa: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Middle East and Africa: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Middle East and Africa: Pneumococcal Vaccine Market: Breakup by Country (in %), 2022
  • Figure 78: Global: Pneumococcal Vaccine Industry: SWOT Analysis
  • Figure 79: Global: Pneumococcal Vaccine Industry: Value Chain Analysis
  • Figure 80: Global: Pneumococcal Vaccine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pneumococcal Vaccine Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Pneumococcal Vaccine Market Forecast: Breakup by Vaccine Type (in Million US$), 2023-2028
  • Table 3: Global: Pneumococcal Vaccine Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 4: Global: Pneumococcal Vaccine Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Pneumococcal Vaccine Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Pneumococcal Vaccine Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Pneumococcal Vaccine Market: Competitive Structure
  • Table 8: Global: Pneumococcal Vaccine Market: Key Players